CAS: 24280-93-1; (E)-6-(4-Hydroxy-6-Methoxy-7-Methyl-3-Oxo-1,3-Dihydroisobenzofuran-5-yl)-4-Methylhex-4-Enoic Acid

该化合物是一种强效免疫抑制剂,有选择地抑制碘酸单磷脱氢酶,从而减少淋巴细胞扩散,抑制免疫反应. 这种选择性行动使得有针对性的治疗能够产生最小的副作用,从而有效地辅助常规治疗,防止移植排斥和自发性疾病.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号31858-66-9 麦考酚酸甲酯-d6(EP杂质E) | CAS号35334-60-2 (E)-6-acetoxy-4... | CAS号100045-79-2 (E)-acetic acid... | CAS号100045-80-5 (E)-1-acetoxy-6... | CAS号100045-81-6 (E)-3-methyl-6-... | CAS号100045-82-7 (E)-8-(tert-but... | CAS号100045-85-0 (E)-2-(6-(tert-... | CAS号100045-86-1 (E)-2-bromo-6-(... | CAS号60435-90-7 6-O-甲基麦考酚酸甲酯 | CAS号31858-66-9 麦考酚酸甲酯-d6(EP杂质E) | CAS号31858-65-8 O-去甲基麦考酚酸 | CAS号527-55-9 4,5-二甲基间苯二酚 | CAS号26675-76-3 7-hydroxy-5-met... | CAS号24243-38-7 3-(5-methoxy-2,... | CAS号27004-95-1 mycophenolate n... | CAS号115007-34-6 吗替麦考吩酯 | CAS号171808-04-1 甲基6’-去甲基-4’-对甲苯... | CAS号171808-03-0 4'-DESMETHYL-6'...

合成工艺路线路线简述

    7-Hydroxy-6-[(E)-6-Hydroxy-3-Methylhex-2-Enyl]-5-Methoxy-4-Methyl-3H-2-Benzofuran-1-One置于jones Reagent体系中,用 丙酮 用作溶剂,化学反应 5.0H,以61%的收率获得霉酚酸
    参考文献:霉酚酸的全合成
    标题:霉酚酸的全合成
    摘要:这些合成 A Partir De T-丁基二甲基甲硅烷氧基-8 (=r-8) 甲氧基-1 甲基-5 辛烯-4Yne-1 和去甲氧基甲氧基甲基-3 (=r'-3) 甲基-2 环丁烯-2One-1 通过环化 De L' 酸 R-3 R'-6 羟基-2 甲氧基-4 甲基-5 苯甲酸
    Doi:10.1021/ja00264A038

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-10973847-B2
    优先权日:2017-06-30
    标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
    发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.

    专利号:WO-2004089946-A1
    优先权日:2003-04-07
    标题:Microwave synthesis of mycophenolate
    发明人:ADHIKARY LAXMI; SURYANARAYAN SHRIKUMAR
    权利人:BIOCON LTD; ADHIKARY LAXMI; SURYANARAYAN SHRIKUMAR
    摘要:A process for synthesis of a compound of formula (I) using microwave irradiation.

    专利号:US-2025236876-A1
    优先权日:2024-01-22
    标题:Engineered yeast for efficient and rapid synthesis of erythritol and construction method thereof
    发明人:CHENG HAIRONG; XU SHUO
    权利人:UNIV SHANGHAI JIAOTONG
    摘要:Disclosed are an engineered yeast for efficient and rapid synthesis of erythritol and a construction method thereof. Yarrowia lipolytica is used as a synthetic chassis for genetic improvement. A method for synthesizing erythritol is as follows: using glucose as a carbon source, and a nitrogen source and an inorganic salt as raw materials, sterilizing a medium, cooling the sterilized medium before inoculating yeast Yarrowia lipolytica , performing continuous fermentation or fed-batch fermentation under the condition of oxygen supply, and purifying erythritol from a fermentation broth. Under the condition of continuous feeding, the yield of erythritol is more than 350 g/L, and the production efficiency is more than 4.5 g/L·h, nearly 100% higher than that of a comparative strain.

    专利号:US-12391691-B2
    优先权日:2018-11-16
    标题:Synthesis of key intermediate of KRAS G12C inhibitor compound
    发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY
    权利人:AMGEN INC
    摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as
    中耀生物科技(苏州)有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.eaststarbio.com
    企业联系电话:18114352668,0512-62620298👤
    📞中耀生物科技(苏州)有限公司 ⚠️参考联系方式
    联系人:陈经理
    电话:18114352668,0512-62620298
    手机:18707272782
    传真:0512-62620298
    邮箱:marketing@eaststarbio.com
    通信地址: 江苏省苏州市苏州工业园218号
    邮编: 215028
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省苏州市苏州工业园218号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    台州市科瑞生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pharm-intermediates.com
    企业联系电话:0576-88813233👤
    📞台州市科瑞生物技术有限公司 ⚠️参考联系方式
    联系人:金崇光
    电话:0576-88813233
    手机:13396860566
    传真:0576-88813233
    邮箱:sales@pharm-intermediates.com
    通信地址: 台州市开发大道东段288号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州市开发大道东段288号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北恒硕化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hengshuochem.com
    企业联系电话:027-82200625;82830253👤
    📞湖北恒硕化工有限公司 ⚠️参考联系方式
    联系人:王硕 徐文琪
    电话:027-82200625;82830253
    手机:13986271535;13995541600
    传真:027-82830253
    邮箱:hengshuochem@163.com
    通信地址: 湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
    邮编: 430014
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州鼎燕化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.dingyanchem.com
    企业联系电话:18267553885👤
    📞杭州鼎燕化工有限公司 ⚠️参考联系方式
    联系人:林女士
    电话:18267553885
    手机:18267553885
    传真:0571-87156470
    邮箱:sales@dingyanchem.com
    通信地址: 杭州市江干区下沙19号大街571号下沙电子商务园4A601-602室
    邮编: 310018
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:杭州市江干区下沙19号大街571号下沙电子商务园4A601-602室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Berti A, Scotti R, Rizzo N, Sabbadini MG, Tresoldi M. Kaposi's Sarcoma in a Patient with Eosinophilic Granulomatosis with Polyangiitis While Taking Mycophenolate Mofetil. J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):431-2. doi: 10.1016/j.jaip.2014.11.023. Epub 2015 Jan 21. Review. Review. Polish. doi: 10.3109/09546634.2014.880395. Epub 2014 Feb 13. Review. doi: 10.1186/1471-2369-15-193. Review.
    5: Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. Immunol Res. 2014 Dec;60(2-3):270-6. doi: 10.1007/s12026-014-8609-x. Review. doi: 10.1111/tri.12382. Epub 2014 Aug 22. Review. doi: 10.1016/j.crohns.2014.01.014. Epub 2014 Feb 4. Review. doi: 10.1002/14651858.CD010280.pub2. Review. Review. doi: 10.1016/j.leukres.2013.12.012. Epub 2013 Dec 25. Review. doi: 10.1002/14651858.CD010242.pub2. Review. doi: 10.1016/j.trre.2013.10.005. Epub 2013 Oct 25. Review. doi: 10.12659/AOT.889299. Review. doi: 10.1097/TP.0b013e31828c6dc7. Review. doi: 10.3109/0886022X.2013.794687. Epub 2013 May 28. Review. doi: 10.1016/j.ijid.2012.11.005. Epub 2012 Dec 5. Review. doi: 10.1111/nep.12006. Review. Review. Polish. doi: 10.1111/j.1365-2125.2012.04305.x. Review.
    20: Hogan J, Schwenk MH, Radhakrishnan J. Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis? Kidney Int. 2012 Dec;82(12):1256-60. doi: 10.1038/ki.2012.203. Epub 2012 May 30. Review.

    合成参考文献


    参考文献:10.2174/092986710790712174
    摘要:Ulinski T, Aoun B. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms. Curr Med Chem. 2010;17(9):847–53. doi: 10.2174/092986710790712174.
    参考文献:10.1177/0961203309355809
    摘要:Habibi S, Agrawal S, Narsimulu G. Mycophenolate: dual utility in rare conditions of HIV infection complicating lupus. Lupus. 2010 May;19(6):774–5. doi: 10.1177/0961203309355809.
    参考文献:10.1111/j.1478-3231.2011.02563.x
    摘要:Saner FH, Cicinnati VR, Sotiropoulos G, Beckebaum S. Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation. Liver Int. 2012 Feb;32(2):179–88. doi: 10.1111/j.1478-3231.2011.02563.x.
    参考文献:10.1016/j.bbmt.2011.06.014
    摘要:Cao W, Xiao H, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Ye X, Yu X, Lin M, Cai Z, Huang H. Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Feb;18(2):273–9. doi: 10.1016/j.bbmt.2011.06.014.
    参考文献:10.1007/s12185-011-0888-6
    摘要:Wakahashi K, Yamamori M, Minagawa K, Ishii S, Nishikawa S, Shimoyama M, Kawano H, Kawano Y, Kawamori Y, Sada A, Matsui T, Katayama Y. Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation. International Journal of Hematology. 2011 Jul 14;94(2):193–202. doi: 10.1007/s12185-011-0888-6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知